======= BARX1 ======= == Gene Information == * **Official Symbol**: BARX1 * **Official Name**: BARX homeobox 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=56033|56033]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q9HBU1|Q9HBU1]] * **Interactions**: [[https://thebiogrid.org/search.php?search=BARX1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20BARX1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603260|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Transcription factor, which is involved in craniofacial development, in odontogenesis and in stomach organogenesis. May have a role in the differentiation of molars from incisors. Plays a role in suppressing endodermal Wnt activity (By similarity). Binds to a regulatory module of the NCAM promoter. {ECO:0000250, ECO:0000269|PubMed:9804553}. |Homeobox| |spleen development| |digestive system development| |negative regulation of Wnt signaling pathway| |anterior/posterior pattern specification| |RNA polymerase II regulatory region sequence-specific DNA binding| |regionalization| |regulation of Wnt signaling pathway| |pattern specification process| |DNA-binding transcription activator activity, RNA polymerase II-specific| |hematopoietic or lymphoid organ development| |immune system development| |DNA-binding transcription factor activity| |epithelial cell differentiation| |epithelium development| |cell-cell signaling| |positive regulation of transcription by RNA polymerase II| |negative regulation of signal transduction| |negative regulation of cell communication| |negative regulation of signaling| |positive regulation of transcription, DNA-templated| |DNA-binding transcription factor activity, RNA polymerase II-specific| |negative regulation of response to stimulus| |positive regulation of nucleic acid-templated transcription| |positive regulation of RNA biosynthetic process| |positive regulation of RNA metabolic process| |tissue development| |positive regulation of nucleobase-containing compound metabolic process| |positive regulation of macromolecule biosynthetic process| |positive regulation of cellular biosynthetic process| |positive regulation of gene expression| |positive regulation of biosynthetic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp53|Suberoylanilide-Hydroxamic-Acid 0.02μM R01 exp53]]|1.91| ^Gene^Correlation^ |[[:human genes:p:prim1|PRIM1]]|0.489| Global Fraction of Cell Lines Where Essential: 0/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|0/28| |bone|0/26| |breast|0/33| |central nervous system|0/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/16| |kidney|0/21| |liver|0/20| |lung|0/75| |lymphocyte|0/16| |ovary|0/26| |pancreas|0/24| |peripheral nervous system|0/16| |plasma cell|0/15| |prostate|0/1| |skin|0/24| |soft tissue|0/9| |thyroid|0/2| |upper aerodigestive|0/22| |urinary tract|0/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 9967 * **Expression level (log2 read counts)**: -7.68 {{:chemogenomics:nalm6 dist.png?nolink |}}